IBB presents an ideal mix between value investing and growth investing. Any pullbacks in IBB should be bought for long-term equity appreciation. IBB is the iShares Biotechnology ETF. IBB tracks ...
You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on 02/05/2001. An increasingly popular option among retail and institutional investors ...
iShares Biotechnology ETF earns an Average Process Pillar rating. Morningstar's algorithmically assigned Passive Process ratings are first formulated by comparing the historical efficacy of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback